Photo via CBC News

Pfizer ends sale of hormone therapy cream Premarin in Canada

Read the original at CBC News ↗
Cite

Roy, M. (2026, November 12). Pfizer ends sale of hormone therapy cream Premarin in Canada. CBC News. https://www.cbc.ca/news/health/pfizer-premarin-menopause-canada-discontinued-9.7419988?cmp=rss

Dated from the outlet's own feed. Check the original for its byline.

CBC News · collected 2026-11-13 · by Mrinalika Roy

Quick Summary

Pfizer has discontinued the sale of its hormone therapy cream Premarin in Canada following an internal review, though oral tablets will remain available until mid-2027. The vaginal cream version has been unavailable since June due to supply issues. The company attributes the discontinuation to supply constraints rather than safety concerns, noting that other treatment options are available. This move comes as demand for hormone replacement therapies increases globally, with concurrent supply shortages affecting other menopause treatments in Canada.
Written by AI on 2026-11-15, from this article's own text only (the story summary below draws on all the coverage).

Compared with similar articles

Nothing to compare against. No article is close enough to this one for the pipeline to have linked or judged the pair.

Story

Pfizer Ends Premarin Sales in Canada
Health · 1 article(s) covering the same event.
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
19
sentences that state something as happening or true
Uncertain
16%
3 of 19 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
72/100
CBC News's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-11-15 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

CBC News · 2286 article(s) · 6 correction(s) detected
Running correction rate · 6 correction(s)

Who wrote this

Mrinalika Roy
1 article(s) here · 1 carrying a prediction
Pfizer will no longer sell its hormone replacement therapy Premarin in Canada following an internal review.
The only article under this byline in the corpus.

Topics

CBC News Canada Pfizer Premarin Reuters

Subjects

Canada GPE · 9× Pfizer ORG · 5× Reuters ORG · 4× CBC News ORG · 2× Bayer ORG · 1× Health Canada ORG · 1× Pfizer Canada ORG · 1× Pfizer Canada’s ORG · 1× the U.S. Food and Drug Association's ORG · 1× the United States GPE · 1×

Narrative

Demand for hormone replacement therapy has been rising, particularly in the United States, where prescriptions have increased following the U.S. Food and Drug Association's November 2025 removal of long-standing safety warnings from the treatments.
framing: assertive · carried by 1 article(s) · first seen 2026-11-15
Pfizer will no longer sell its hormone replacement therapy Premarin in Canada following an internal review.
2026-11-15 · CBC News
Pfizer ends sale of hormone therapy cream Premarin in Canada · assertive framing

Claims (19 extracted, 3 hedged)

Pfizer ends sale of hormone therapy cream Premarin in Canada Other hormone replacement products prescribed to treat menopause also facing supply constraints asserted
products → end → constraints
Pfizer will no longer sell its hormone replacement therapy Premarin in Canada following an internal review. asserted
Pfizer → sell → review
Premarin vaginal cream, which is used to treat symptoms of menopause, is currently unavailable and will not be returning, CBC News has confirmed. asserted
News → use → menopause
According to Pfizer Canada’s pharmaceutical customer service centre, the company will no longer be marketing Premarin vaginal cream and Premarin tablets, although the tablets are expected to remain available through mid-2027. uncertain
tablets → accord → mid-2027
Pfizer Canada told Reuters that there's been a shortage of the vaginal cream in Canada since June. asserted
Canada → tell → June
Demand for hormone replacement therapy has been rising, particularly in the United States, where prescriptions have increased following the U.S. Food and Drug Association's November 2025 removal of long-standing safety warnings from the treatments. asserted
prescriptions → rise → treatments
Some other hormone therapy products to treat menopause symptoms are also facing supply constraints in Canada. asserted
products → treat → Canada
Earlier this month, Health Canada said certain strengths of estradiol transdermal patches made by Bayer and Sandoz Canada were in short supply, with intermittent shortages expected to continue until early 2027. asserted
shortages → say → 2027
The discontinuation of Premarin products, alongside shortages of some estradiol patches, could add to pressure on Canada's menopause drug supply. uncertain
discontinuation → add → supply
Unmanaged menopause symptoms cost Canada's economy $3.5B, experts tell MPs More women are taking testosterone to treat menopause symptoms. asserted
women → cost → symptoms
Does science support that? asserted
science → support → that
The decision was not related to any new safety, efficacy or quality concerns, Pfizer told Reuters, adding that other treatment options were available in Canada. asserted
options → relate → Canada
Existing inventories of Premarin tablets in 0.3 milligram, 0.625 mg and 1.25 mg strengths are expected to last until about mid-2027, although stocks could run out sooner if demand increases, the company said. uncertain
company → exist → mid-2027
The move follows a separate supply disruption in India, where Pfizer suspended sales of Premarin vaginal cream in July, Reuters reported at the time. asserted
Reuters → follow → time
The company had said it was exploring options to resume supplies. asserted
it → say → supplies
Pfizer said its latest decision applied only to Canada and declined to comment on supply situations in other markets, Reuters reported. asserted
Reuters → say → markets
The treatment contains a mixture of estrogen hormones and is prescribed to treat vaginal dryness, painful intercourse and other symptoms of menopause caused by declining estrogen levels. asserted
treatment → contain → levels
Premarin cream and tablets are sold around the world, including in the U.S., Canada, New Zealand, Australia and Singapore. asserted
cream → sell → U.S.
Premarin Intravenous, used in hospitals for the treatment of abnormal uterine bleeding due to hormonal imbalance, is not affected. asserted
Intravenous → use → imbalance
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support